Ignite Creation Date:
2024-05-06 @ 3:43 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02352571
Status:
UNKNOWN
Last Update Posted:
2016-07-06
First Post:
2015-01-21
Brief Title:
Safety Study of GC1118 Recombinant Human Anti-EGFR Antibody in Patients With Advanced Solid Cancer
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-06
Completion Date Type:
ESTIMATED
First Submit Date:
2015-01-21
First Submit QC Date:
January 28 2015
Study First Post Date:
2015-02-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-04
Last Update Post Date:
2016-07-06
Last Update Post Date Type:
ESTIMATED